A Study to Investigate Safety and Tolerability of SH3765 Tablet in Patients With Advanced Malignant Tumor
Clinical trial NCT05015309 · UNKNOWN
Trial details
- NCT number
- NCT05015309
- Sponsor
- Nanjing Sanhome Pharmaceutical, Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2023-03-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.